Fundraising Fox
🦊/People
Sign in

Mohan S. Iyer

Investor

General Partner at SOSV · General Partner at IndieBio · Board director at Cellens

San Francisco, California

Writes $100K – $2M checks · typically $1M

Find your path to Mohan

362 people in our graph share verified history with Mohan — schools, employers, funds. One of them is your warm intro.

Michelle ModestunlockedMohan: together at IndieBio (2022)
Mohan: together at Yale School of Management
Mohan: together at Indiebio
Mohan: together at IndieBio

About

General Partner at SOSV SF with over 25 years as an entrepreneur and leader across life science startups, experienced in strategy, team building, fundraising, and M&A and strategic partnering deals.

Board director at Cellens

Intro paths

→

In turn, Mohan can intro founders to Cellens's investors below.

Cellens's investors · 1

IndieBioSan Francisco · $525K checks · since 2025

Co-founders at Cellens

P(
Phuong (Jean) PhamCEO

Experience

  1. IndieBioGeneral Partnercurrent2021 — presentSan Francisco, California, United States
  2. Pendulum TherapeuticsCOO2017 — 2021
  3. Second Genome, Inc.Chief Business Officer2012 — 2017
  4. Tethys Bioscience, Inc.CFO2011
  5. Tethys Bioscience, Inc.Chief Business Officer2009 — 2011
  6. Burrill & CompanyManaging Director, Merchant Banking2006 — 2009
  7. diaDexusEVP, Corporate and Business Development1997 — 2005
  8. The Wilkerson Group (IBM Healthcare Consulting)Senior Healthcare Consultant1995 — 1997
  9. Genentech Inc.Senior Process Engineer1986 — 1993

Skills & more

Mergers10Strategy35Business Development19Biotechnology43Lifesciences12Commercialization18Corporate Development19Venture Capital9Pharmaceutical Industry15Medical Devices16Technology Transfer11Start-ups13
+12 moreOncologyClinical DevelopmentDue DiligenceProduct LaunchDrug DiscoveryMergers & AcquisitionsGlobal MarketingStrategic PartnershipsDrug DevelopmentCross-functional Team LeadershipR&DBiopharmaceuticals

Languages Tamil

From Mohan's professional profile.

Investments

Investor

Antarka BioAugment BiologicsBlaze Energy TechnologiesCalifornia Perovskite TechnologyCellensDisperseBioEndarisFermeateFinish Line BioFLOUVGilly BiotechnologiesInixi BioLambda energyLogos AIMetabolic Psychiatry LabsMetabolizeOncoPrecisionPost Translational MedicinesProton IntelligenceReefstarterSupercool EarthSynplexitySyntheXTransition Metal SolutionsUnlocked LabsXtelligence

Per curated public sources.

Colleagues at SOSV

Alan Clayton
Investor at SOSV
Alex Kopelyan
Partner at SOSV
Alexander Hall-Daniels
Principal at SOSV
Andrew Gollach
Partner at SOSV
Avra van der Zee
General Partner, SOSV at HAX
Benjamin Joffe
Partner at SOSV
Bill Liao
General Partner at SOSV
Bradford Higgins
Venture Partner at SOSV

Frequently asked questions

Who is Mohan S. Iyer?
General Partner at SOSV SF with over 25 years as an entrepreneur and leader across life science startups, experienced in strategy, team building, fundraising, and M&A and strategic partnering deals.
Where does Mohan S. Iyer work?
Mohan S. Iyer is General Partner at SOSV and Board director at Cellens.
What check size does Mohan S. Iyer write?
Mohan S. Iyer typically writes checks of $100K – $2M.
What companies has Mohan S. Iyer invested in?
Investments tracked here include Antarka Bio, Augment Biologics, Blaze Energy Technologies, California Perovskite Technology, Cellens, DisperseBio, Endaris, Fermeate, Finish Line Bio, FLOUV, Gilly Biotechnologies, Inixi Bio, and 14 more.
Where did Mohan S. Iyer go to school?
Mohan S. Iyer studied at Yale School of Management (MBA); Duke University (MS, Biomedical Engineering); University of Tennessee, Knoxville (B.S., Chemical Engineering).

Same school

Shared employers